首页> 中文期刊> 《中外医疗》 >温肺化瘀定喘用于小儿风寒闭肺证病毒性毛细支气管炎的临床疗效及安全性分析

温肺化瘀定喘用于小儿风寒闭肺证病毒性毛细支气管炎的临床疗效及安全性分析

         

摘要

Objective To explore the efficacy and safety of the method of lung warming, stasis transforming and panting stabilizing in treating wind-cold blocking lung-type viral bronchiolitis in Children. Methods 42 children with viral bronchiolitis admitted to our hospital during April 2013 and April 2014 were selected as the observation group in which the method of lung warming, stasis transforming and panting stabilizing was used, and 42 other children with the same disease admitted to our hospital during the same period were selected as the control group in which the inhalation therapy was used. The clinical efficacy and safety of the two groups were compared. Results The therapeutic effect of the two groups were 92.9% and 90.5%,P>0.05; the time of fever, cough, wheeze extinction of the observation group were shorter than those of the control group, P<0.05; the recurrence rate of the observation group,2.6%, was significantly lower than that of the control group 15.8%, P<0.05; no serious adverse drug reactions was found in both of the two groups. Conclusion In the treatment of wind-cold blocking lung-type viral bronchiolitis in Children, the method of lung warming, stasis transforming and panting stabilizing can improve the clinical symptoms in the short term and has high medication safety.%目的:探究温肺化瘀定喘治疗小儿风寒闭肺证病毒性毛细支气管炎的疗效及安全性。方法整群选择2013年4月-2014年4月期间该院收治的42例小儿毒性毛细支气管炎患儿作为观察组行温肺化瘀定喘法治疗,另取同期收治同症患儿42例作为对照组行雾化吸入治疗,观察对比两组临床疗效及安全性。结果两组疗效分别为92.9%和90.5%(P>0.05);观察组发热、咳嗽、憋喘消退时间均短于对照组(P>0.05);观察组复发率为2.6%,明显低于对照组的15.8%(P>0.05);均未发生严重药物不良反应。结论该疗法治疗小儿风寒闭肺证病毒性毛细支气管炎的临床疗效确切,可短期内改善临床症状,且用药安全性较高。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号